Levaquin: Potent Antibiotic for Serious Bacterial Infections
Levaquin
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.70 | $51.00 (0%) | 🛒 Add to cart |
| 60 | $1.50 | $102.00 $90.00 (12%) | 🛒 Add to cart |
| 90 | $1.30 | $153.00 $117.00 (24%) | 🛒 Add to cart |
| 120 | $1.15 | $204.00 $138.00 (32%) | 🛒 Add to cart |
| 180 | $1.00 | $306.00 $180.00 (41%) | 🛒 Add to cart |
| 270 | $0.90 | $459.00 $243.00 (47%) | 🛒 Add to cart |
| 360 | $0.87
Best per pill | $612.00 $313.00 (49%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.00 | $40.00 (0%) | 🛒 Add to cart |
| 30 | $1.90 | $60.00 $57.00 (5%) | 🛒 Add to cart |
| 60 | $1.80 | $120.00 $108.00 (10%) | 🛒 Add to cart |
| 90 | $1.64 | $180.00 $148.00 (18%) | 🛒 Add to cart |
| 120 | $1.50 | $240.00 $180.00 (25%) | 🛒 Add to cart |
| 180 | $1.25 | $360.00 $225.00 (38%) | 🛒 Add to cart |
| 270 | $1.13 | $540.00 $305.00 (44%) | 🛒 Add to cart |
| 360 | $1.03
Best per pill | $720.00 $370.00 (49%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $2.20 | $44.00 (0%) | 🛒 Add to cart |
| 30 | $2.00 | $66.00 $60.00 (9%) | 🛒 Add to cart |
| 60 | $1.90 | $132.00 $114.00 (14%) | 🛒 Add to cart |
| 90 | $1.70 | $198.00 $153.00 (23%) | 🛒 Add to cart |
| 120 | $1.60 | $264.00 $192.00 (27%) | 🛒 Add to cart |
| 180 | $1.40 | $396.00 $252.00 (36%) | 🛒 Add to cart |
| 270 | $1.32 | $594.00 $356.00 (40%) | 🛒 Add to cart |
| 360 | $1.20
Best per pill | $792.00 $432.00 (45%) | 🛒 Add to cart |
Synonyms
| |||
Levaquin (levofloxacin) is a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of adults with serious bacterial infections. It demonstrates excellent tissue penetration and bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens. This medication is reserved for cases where first-line antibiotics have failed or are inappropriate due to resistance patterns or patient factors. Proper diagnosis and antimicrobial stewardship are essential when considering Levaquin therapy.
Features
- Active ingredient: Levofloxacin (250mg, 500mg, 750mg tablets; IV solution)
- Mechanism: DNA gyrase and topoisomerase IV inhibition
- Spectrum: Broad coverage including Pseudomonas aeruginosa, Streptococcus pneumoniae, and many Enterobacteriaceae
- Bioavailability: Approximately 99% oral bioavailability
- Half-life: 6–8 hours permitting once-daily dosing
Benefits
- Effective against multidrug-resistant pathogens where other antibiotics fail
- Excellent penetration into lung tissue, prostate, and skin structures
- Convenient once-daily dosing regimen improves compliance
- Available in both oral and intravenous formulations for seamless transition
- Rapid bactericidal action reduces bacterial load quickly
- Proven efficacy in complicated urinary tract and respiratory infections
Common use
Levaquin is commonly prescribed for complicated urinary tract infections, including pyelonephritis, particularly when caused by multidrug-resistant organisms. It is frequently used in hospital-acquired pneumonia and community-acquired pneumonia in patients with comorbidities. Other indications include chronic bacterial prostatitis, complicated skin and skin structure infections, and as part of combination therapy for certain mycobacterial infections. It may be used for acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis when benefit outweighs risk.
Dosage and direction
The recommended dosage varies by indication and severity. For complicated urinary tract infections or acute pyelonephritis: 250mg once daily for 10 days. For community-acquired pneumonia: 500mg once daily for 7–14 days. For complicated skin infections: 750mg once daily for 7–14 days. Administer tablets with water, with or without food, but avoid antacids, sucralfate, or multivitamins containing iron or zinc within 2 hours of dosing. For intravenous administration, infuse 250mg or 500mg over 60 minutes, or 750mg over 90 minutes. Dosage adjustment required in renal impairment (CrCl <50 mL/min).
Precautions
Monitor for tendonitis or tendon rupture, which may occur during or after therapy, particularly in elderly patients and those taking corticosteroids. Avoid excessive sunlight exposure due to photosensitivity risk. Use with caution in patients with known or suspected central nervous system disorders that may predispose to seizures. Monitor blood glucose levels carefully in diabetic patients. May prolong QT interval; avoid in patients with known QT prolongation, uncorrected hypokalemia, or taking other QT-prolonging drugs. Peripheral neuropathy may occur and can be irreversible.
Contraindications
Known hypersensitivity to levofloxacin or other quinolone antibiotics. History of tendon disorders related to fluoroquinolone use. Contraindicated in patients with myasthenia gravis due to risk of exacerbation. Not recommended in pediatric patients (except for specific indications like inhalation anthrax) or during pregnancy due to potential effects on cartilage development. Avoid concurrent administration with tizanidine.
Possible side effect
Common side effects include nausea (3–5%), diarrhea (2–4%), headache (2–4%), and constipation (2–3%). Less frequent but serious adverse reactions include tendon rupture (particularly Achilles tendon), peripheral neuropathy, central nervous system effects (dizziness, insomnia, anxiety), QT prolongation, hypoglycemia, and photosensitivity reactions. Clostridium difficile-associated diarrhea may occur. Rare cases of hepatotoxicity, blood dyscrasias, and severe skin reactions have been reported.
Drug interaction
Antacids containing magnesium or aluminum, sucralfate, iron preparations, and zinc supplements significantly reduce absorption—separate administration by at least 2 hours. Nonsteroidal anti-inflammatory drugs may increase CNS stimulation and seizure risk. May enhance effects of warfarin—monitor INR closely. Corticosteroids increase risk of tendon rupture. Drugs that prolong QT interval (antiarrhythmics, antipsychotics, macrolides) should be used with extreme caution. May affect blood glucose levels when used with antidiabetic agents.
Missed dose
Take the missed dose as soon as remembered, unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain the regular dosing schedule. If multiple doses are missed, contact healthcare provider for guidance on resuming therapy.
Overdose
Symptoms may include dizziness, tremors, seizures, confusion, and gastrointestinal distress. Management is supportive with ECG monitoring for QT prolongation. Hemodialysis removes approximately 10–15% of the dose. Maintain adequate hydration. Specific antidote is not available. Contact poison control center immediately for guidance.
Storage
Store tablets at room temperature (15–30°C or 59–86°F) in original container, protected from light and moisture. Keep out of reach of children. Do not use if tablets are discolored or show signs of deterioration. Intravenous solution should be stored according to manufacturer’s instructions and used within specified time after preparation.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Levaquin is a prescription medication that should be used only under supervision of a qualified healthcare provider. The healthcare provider should assess risks and benefits based on individual patient factors. Patients should report any unusual symptoms immediately. Antibiotic resistance is a serious public health concern—use only when medically appropriate.
Reviews
Clinical studies demonstrate Levaquin’s efficacy in approved indications, with success rates of 85–95% in appropriately selected patients. Many infectious disease specialists note its value in treating multidrug-resistant infections when alternatives are limited. However, experts increasingly recommend reserving fluoroquinolones for cases where no safer alternatives exist due to risk profile. Patient experiences vary, with some reporting rapid resolution of serious infections while others describe significant adverse effects. The medical community continues to reassess fluoroquinolone use through the lens of antimicrobial stewardship and risk-benefit analysis.